TrialIntensive care medicine2018

Phase 1 safety and pharmacokinetic study on the use of pioglitazone in critically ill patients with sepsis: a randomized clinical trial.

Jennifer M Kaplan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.